Franciosi Consulting Investigating Beta-Adrenergic Receptor Antagonists as Potential New Treatments for Essential Tremor
05 janv. 2022 12h00 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. will be performing structure activity analyses of published beta-adrenergic receptor antagonists (a.k.a. beta...
Global Toxicology Services Market Outlook 2021-2028 by Study Method, Industry, End-Point and Region
25 nov. 2021 05h23 HE
|
Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Toxicology Services Global Market - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. According to analysis, the global...
Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility
10 nov. 2021 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 10, 2021 (GLOBE NEWSWIRE) -- November 10, 2021 -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization...
Global Live Cell Imaging Markets Research Report 2021-2027: Focus on Fluorescence Resonance Energy Transfer & High Content Screening
03 nov. 2021 10h58 HE
|
Research and Markets
Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market based on Product, Application, Technology - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's...
Worldwide Preclinical CRO Industry to 2028 - Featuring Wuxi App, Medpace and ICON Among Others
12 oct. 2021 07h43 HE
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use...
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
04 oct. 2021 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
NIH/NINDS Awards AnaBios With $1.7M Grant to Develop Novel Analgesic for Mixed Inflammatory, Neuropathic Pain States
30 sept. 2021 11h00 HE
|
AnaBios
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded AnaBios a $1,734,409...
Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories
02 août 2021 12h15 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
27 mai 2021 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings
11 mai 2021 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...